Writer says equipping AED first-aid boxes with easy administration of epinephrine and naloxone could save more lives.
Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...
During a severe allergic reaction (anaphylaxis), children who received epinephrine before arriving at the hospital are less ...
The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...
A recent study conducted by the Montreal Children’s Hospital (MCH) has found that children who receive epinephrine -- after a ...
Aquestive Therapeutics’ Anaphylm AQST-109 epinephrine sublingual film demonstrated durability despite testing in extreme ...
The US Food and Drug Administration (FDA) has approved Neffy, a nasal spray for treating severe allergic reactions in ...
Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...